Altasciences, a full-service early-phase contract research organization, is proud to have partnered with Metsera, Inc., a clinical-stage biopharmaceutical company dedicated to advancing next-generation therapies for obesity and metabolic diseases. This…
The World Health Organization (WHO) has published a new report titled Safe, Climate-Resilient, and Environmentally Sustainable Healthcare Facilities: An Overview. This guide offers policymakers, health administrators, facility managers, and healthcare…
The Director-General of the World Health Organization (WHO) has released the report from the second meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the mpox outbreak of…
Genentech, part of the Roche Group, has provided an update on the Phase III SKYSCRAPER-01 study, which evaluated the combination of tiragolumab with Tecentriq® (atezolizumab) compared to Tecentriq alone in…
Menarini Presents Data at SABCS 2024 Showcasing ORSERDU®’s Potential in ER+/HER2- Metastatic Breast Cancer The Menarini Group and its subsidiary, Stemline Therapeutics, are set to unveil new and expanded findings…
Exact Sciences Highlights the Impact of Oncotype DX® and Genomic Insights at SABCS 2024 Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, will present a robust array of…
Bicycle Therapeutics to Present Key Zelenectide Pevedotin Data at SABCS 2024 and Share Program Updates Bicycle Therapeutics plc (NASDAQ: BCYC), a company at the forefront of developing a novel therapeutic…
Enanta Pharmaceuticals Delivers Key Updates on Virology and Immunology Programs While Reporting Fiscal Year 2024 Results Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company specializing in small molecule drugs…
The Quadripartite organizations – the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP), the World Health Organization (WHO), and the World Organisation for…
Since October 7, 2023, Lebanon has experienced an alarming escalation in attacks on health care, with nearly half of these assaults proving fatal to health workers or patients. As of…
Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced it has withdrawn its non-binding proposal to acquire Evotec SE (NASDAQ: EVO) at €11.00 per share in cash, representing a fully diluted equity value…
Cancer treatments are evolving, with increasing focus on using the body’s immune defenses to combat the disease. Reetta Virtakoivu, Senior Scientist at Orion, explains how immunotherapy works and why it…